Literature DB >> 16927181

Solute crystallization in frozen systems-use of synchrotron radiation to improve sensitivity.

Dushyant B Varshney1, Satyendra Kumar, Evgenyi Y Shalaev, Shin-Woong Kang, Larry A Gatlin, Raj Suryanarayanan.   

Abstract

PURPOSE: To demonstrate the sensitivity of low temperature synchrotron X-ray diffractometry (SXRD) for detecting solute crystallization in frozen sodium phosphate buffer solutions. To determine the effect of annealing on solute crystallization in frozen solutions.
MATERIALS AND METHODS: Sodium phosphate buffer solutions, at initial buffer concentrations ranging from 1 to 100 mM (pH 7.4) were cooled to -50 degrees C. The crystallization of disodium hydrogen phosphate dodecahydrate (Na(2)HPO(4) *12H(2)O) was monitored using a laboratory as well as a synchrotron source. At selected concentrations, the effect of annealing (at -20 degrees C) was investigated.
RESULTS: With the laboratory source, solute crystallization, based on the appearance of one diagnostic peak with a d-spacing of 5.4 A, was evident only when the initial buffer concentration was at least 50 mM. In contrast, using SXRD, crystallization was detected at initial buffer concentrations down to 1 mM. In addition, the use of a high-resolution 2D detector enabled the visualization of numerous diffraction rings of the crystalline solute. At both 10 and 100 mM buffer concentration, there was no increase in solute crystallization due to annealing.
CONCLUSION: By using synchrotron radiation, solute crystallization was detected with substantially increased sensitivity, making the technique useful for freeze-drying cycles of practical and commercial importance. Since numerous peaks of the crystalline solute appeared, the technique has potential utility in complex, multi-component systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927181     DOI: 10.1007/s11095-006-9051-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry.

Authors:  Cletus Nunes; Arumugam Mahendrasingam; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-08-31       Impact factor: 4.200

2.  Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry.

Authors:  M P te Booy; R A de Ruiter; A L de Meere
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

3.  Studies on stability of drugs in frozen systems. IV. The stability of benzylpenicillin sodium in frozen aqueous solutions.

Authors:  S S Larsen
Journal:  Dan Tidsskr Farm       Date:  1971

4.  Phase transitions of glycine in frozen aqueous solutions and during freeze-drying.

Authors:  A Pyne; R Suryanarayanan
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

5.  Effect of initial buffer composition on pH changes during far-from-equilibrium freezing of sodium phosphate buffer solutions.

Authors:  G Gómez; M J Pikal; N Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

6.  Monitoring dehydration and condensation processes of Na2HPO4*12H2O using thermo-Raman spectroscopy.

Authors:  Anil Ghule; Chetan Bhongale; Hua Chang
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2003-05       Impact factor: 4.098

7.  Characterization of frozen aqueous solutions by low temperature X-ray powder diffractometry.

Authors:  R K Cavatur; R Suryanarayanan
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

8.  Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength.

Authors:  M J Akers; N Milton; S R Byrn; S L Nail
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

9.  The effects of formulation variables on the stability of freeze-dried human growth hormone.

Authors:  M J Pikal; K M Dellerman; M L Roy; R M Riggin
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

10.  Characterization and crystal structure of D-mannitol hemihydrate.

Authors:  Cletus Nunes; Raj Suryanarayanan; Cristian E Botez; Peter W Stephens
Journal:  J Pharm Sci       Date:  2004-11       Impact factor: 3.534

View more
  6 in total

1.  Effect of Formulation and Process Parameters on the Disproportionation of Indomethacin Sodium in Buffered Lyophilized Formulations.

Authors:  Sampada Koranne; Seema Thakral; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

2.  Glycine crystallization in frozen and freeze-dried systems: effect of pH and buffer concentration.

Authors:  Dushyant B Varshney; Satyendra Kumar; Evgenyi Y Shalaev; Prakash Sundaramurthi; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

3.  Ultrasonication as a potential tool to predict solute crystallization in freeze-concentrates.

Authors:  Vishard Ragoonanan; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2014-01-08       Impact factor: 4.200

4.  Phase transitions in frozen systems and during freeze-drying: quantification using synchrotron X-ray diffractometry.

Authors:  Dushyant B Varshney; Prakash Sundaramurthi; Satyendra Kumar; Evgenyi Y Shalaev; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2009-03-27       Impact factor: 4.200

5.  Protein/Ice Interaction: High-Resolution Synchrotron X-ray Diffraction Differentiates Pharmaceutical Proteins from Lysozyme.

Authors:  Bakul Bhatnagar; Boris Zakharov; Alexander Fisyuk; Xin Wen; Fawziya Karim; Kimberly Lee; Yurii Seryotkin; Mashikoane Mogodi; Andy Fitch; Elena Boldyreva; Anastasia Kostyuchenko; Evgenyi Shalaev
Journal:  J Phys Chem B       Date:  2019-07-01       Impact factor: 3.466

6.  Synchrotron X-ray diffraction to detect glass or ice formation in the vitrified bovine cumulus-oocyte complexes and morulae.

Authors:  Muhammad Anzar; Pawel Grochulski; Brennan Bonnet
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.